InsiderDB

Lobbying disclosures · Lobbying report

BMY: second_quarter 2026 lobbying report

Access to prescription drugs. Policies related to 340B. Drug Pricing reform/implementation. Food is Medicine initiatives. Issues related to the budget and appropriations process

Follow BMY
Became public
Jul 20, 2026, 10:45 PM EDT
Event / period date
Not stated
Collected
Nov 10, 2026, 4:38 PM EST

Why this is connected

Legal-name match: BRISTOL MYERS SQUIBB COMPANY is BRISTOL MYERS SQUIBB CO (https://www.sec.gov/Archives/edgar/data/14272/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Reported lobbying amounts

Income: $50,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/27e29a0f-8f2d-4a30-b234-3f7dfbcb14e1/","filing_uuid":"27e29a0f-8f2d-4a30-b234-3f7dfbcb14e1","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/27e29a0f-8f2d-4a30-b234-3f7dfbcb14e1/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Paul A. Brathwaite","dt_posted":"2026-07-20T22:45:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1220 L Street, NW","registrant_address_2":"Suite 100-401","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401104703,"url":"https://lda.gov/api/v1/registrants/401104703/","house_registrant_id":null,"name":"FEDERAL STREET STRATEGIES, LLC","description":"Government relations and public policy consulting firm","address_1":"1220 L Street, NW","address_2":"Suite 100-401","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL BRATHWAITE","contact_telephone":"+1 202-274-1099","dt_updated":"2026-07-30T23:17:42.705814-04:00"},"client":{"id":44609,"url":"https://lda.gov/api/v1/clients/44609/","client_id":44609,"name":"BRISTOL MYERS SQUIBB COMPANY","general_description":"Global biopharmaceutical company.","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to prescription drugs. Policies related to 340B. Drug Pricing reform/implementation. Food is Medicine initiatives. Issues related to the budget and appropriations process","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67337,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"BRATHWAITE","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor.","new":false},{"lobbyist":{"id":142566,"prefix":null,"prefix_display":null,"first_name":"VEN","nickname":null,"middle_name":null,"last_name":"NERALLA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff,U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep.Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio;Senior Advisor, USDA; OPP; and MCC.","new":true},{"lobbyist":{"id":147906,"prefix":null,"prefix_display":null,"first_name":"KAADE","nickname":null,"middle_name":null,"last_name":"WALLACE","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum","new":true},{"lobbyist":{"id":147905,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"LEAVANDOSKY","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in BMY

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.